Kromek Share Discussion Threads

[aqc888] 07/9/2021 19:46

QuePassa,

Kromek agreed to build these ventilators at a time of national crisis and panic. A time when Astra Zeneca agreed to make vaccines with zero margin. A time when various other UK businesses such as Dyson were persuaded to make ventilators- only to have sold zero ventilators like Kromek.

The reason for this is that only the most severe patients in intensive care were given ventilators- less ill patients in hospital were given oxygen. There were never enough intensive care nurses to go with the ventilators. It was an error that with hindsight we can see the government made, requesting various manufacturers to make ventilators. In the end they sourced a load of faulty ones from China that went straight into storage. Kromek can be blamed for not updating the market with an RNS feed. But not for the ventilator fiasco.

[quepassa] 07/9/2021 19:35

Last year they said they were well placed for manufacturing and selling VENTILATORS under license from Metran.

Anyone recall how many ventilators Kromek said they had sold in the UK when asked that question two or three months ago?

[deedledee] 07/9/2021 19:14

Thanks Nick. A lot of promise there. AGM should be interesting.Given the responses perhaps today's sellers may yet rue their sales.

[nick2412] 07/9/2021 18:45

I heard back from Kromek with very helpful replies and will post the gist as it's not good etiquette to do a copy and paste.

Competitors?

Reply summmary:- Not aware of any with fully autonomous air sampling and diagnostic technologies with the capabilities of the Kromek-developed system.

Reply summary:- Some very early stage technologies : collect air samples but no capability to autonomously analyse the sample. Needs human intervention to produce a report and this would generally be in a laboratory.

When will the machines be commercially available?

Reply aummary:- Both within this fiscal year.

My note: I believe the Covid specific machine is due to be the first commercial launch.

Barriers to entry? Patents?

Reply summary:- Significant barriers to entry. KMK have a two year head start due to funded development that commenced in 2018. Further $13m development funds from DAPRA. Patents? Taking out patents on various aspects for both the Covid detector and the 'agnostic' bio-detecton technologies.


Expectations on KMK taking some of the UK Govt planned extra spend in the nuclear security / detection sector?

Reply summary:- Yes, well placed with portfolio of products, especially with the addition of the new D5 handheld device, to capitalise on that announced government spend.

Medical scanners £47m 7 year contract roll-out?

reply summary:- Yes progressing as planned - in line with the contract.

Benefit from UK Govt flagged up extra spend on nuclear detection / security?

Reply summary:- Yes, we believe we are well placed with our product portfolio, particularly with the addition of the new D5 handheld device, to capitalise on that announced government spend.

[dexter1612] 07/9/2021 18:09

Yeah we're all doomed.

[b00mb0y] 07/9/2021 16:24

Has the light at the end of the tunnel been extinguished? AGM tomorrow. Showcase next week. More sells than buys. Is it all over now. Nobody has any faith left in this stock

[33mick] 06/9/2021 20:01

The White House wants $65 billion for an ‘Apollo’-style pandemic preparedness program
By Lev Facher Sept. 3, 2021

"The immense funding boost would target programs aimed at developing and manufacturing vaccines, treatments, and tests more quickly. It would also provide new money for laboratory capacity, viral detection mechanisms, and early warning systems."

"It would include $3.1 billion aimed at establishing an early-warning system for new disease outbreaks, including systems to sequence pathogens found in wastewater and a “reliable clinical surveillance system.”

[nick2412] 06/9/2021 14:09

AQ, yes there are consumables which makes things interesting. Paul Hill, analyst for Equity Development, highlighted that the estimated market is £500m for bio-threat detectors and he projected that Kromek could take 20% with good profit margins. He added (Jan '21) :-

"But assuming Kromek captured 20%, this would represent a £100m pa opportunity, probably generating 25% drop through rates to boot. Which in valuation terms, using 3x sales &/or 12x EBIT multiples – might lift the market cap by £300m"


dev elopment.co.uk/hubfs/Research/Kromek/Kromek%20Group%20%20%20%2013%20%20January%202021.pdf

Just take out the space in the link as advfn's software automatically edits out links from ED.


He also highlighted there would be revenues from consumables derived from 'daily sampling' for the machines hence my question along the lines of:- how do Kromek assess the split in revenues between machine sales and consumables?

I'll be interested in the reply to your question about whether it will just be an all in one machine but I am anticipate there will be a cheaper Covid only detector that will be rolled out first then the secondary machine that will cover all bio-threats that will have both civil and military markets. Presumably the latter will be much more expensive. Whether there will be a third Covid plus other pathogens machine for civil markets I don't know.

[aqc888] 06/9/2021 12:37

I’d be interested to know what sectors have expressed the most interest in the detector ie Health, travel, education, governments..

Will Kromek release a covid detector and then later a pathogen detector that will detect all pathogens. Or will they release one that senses all pathogens.

Is the covid detector they have developed upgradable to sense other pathogens. Will the next generation detector require new hardware or just a software upgrade? (I guess this will be an important aspect governments will consider in considering how many to purchase).

How much on going revenue will the machines generate for Kromek? Are there many consumables, does it require much in the way of servicing?

[nick2412] 06/9/2021 11:45

Thanks AQ, looks like it is all in hand as holders would expect.

I have just submitted these queries to the email KMK have set up for AGM queries. It's [e-mail] in case anyone else has other questions.

1) For the Covid and other health threat virus detector, what use is it in an area of a very large number of people such as a stadium, shopping centre or airport given it doesn’t identify who has the virus and should therefore isolate immediately? In other words what helpful actions does the detector prompt when signalling virus detection for the purchaser of the product?

2) What competition does Kromek perceive exists for the bio-threat detection market?

3) Can Kromek provide an estimate of the % of the potential bio-threat detection market it is targeting?

4) Can you give updated guidance on when the Covid specific product is likely to be released for commercial sales and, likewise, for the broader bio-threat product?

5) What are the barriers to entry for potential competitors? Is Kromek strengthening its patent position?

6) Are you able to give a likely split on the revenues anticipated from machine sales and the recurring revenues from daily sampling?

7) The UK Govt has projected it will spend over £300m on nuclear threat security and detection. Do you perceive Kromek is in a good position to be a recipient of some of this spend?

8) Regarding the medical imaging scanners with the £42m 7 year contract, is rollout accelerating?

[fanramptastic mate] 06/9/2021 10:48

i like the sound of that

[aqc888] 06/9/2021 10:42

The CFO just replied to the question, that was quick...

Dear Andrew

Thank you for your email.

With regard to the biological pathogen detection system that we have developed, we have entered into a supply agreement with a global third-party contract manufacturing company to manufacture and assemble the systems. This is a scalable arrangement and is able to respond as necessary to customer demand.

Best regards

Paul

[aqc888] 06/9/2021 09:24

Just submitted my question:

How many biological pathogen detectors could Kromek make per annum, should the detector work as hoped?

[aqc888] 06/9/2021 08:38

It’s got to be 50:50 whether the results of the biological pathogen detector are released on Wednesday I’d think. If the results are as good as the CEO and ST have claimed I’d expect this to easily go to 25p by the end of the week. Remember, Kromek have claimed to be in serious discussions with multiple governments around the world regarding the detector. Wednesday could be the day detector results and news of sales are announced.

[strategicinvestor2] 06/9/2021 07:42

Could be the week for move much higher…

[33mick] 05/9/2021 19:24

Airborne transmission of viruses ‘more prevalent than previously recognized’

“Small viral particles remaining in the air, long after an individual [with the infection] has left an area, can still [cause infection in] an otherwise healthy [person]. It should sound an alarm on rethinking how healthcare providers and public health officials approach respiratory diseases, especially COVID-19, that continues to evade full scientific and clinical understanding."


medicalnewstoday.com: Most respiratory viruses spread by aerosols, according to review.



Must be due for some update news very soon I hope.

[aqc888] 04/9/2021 21:00

Could easily see this reach 25p by the end of the week with some concrete good news regarding the detector

[aqc888] 04/9/2021 20:26

Part of the purpose of an AGM is “ informing the members of previous and future activities”. So I’d hope that some ‘informingR17; regarding the biological pathogen detector will take place. With proper details investors can hang their hats on.

[quepassa] 04/9/2021 20:01

if you get a concrete response to that leading question from anyone, i'll eat my hat

all imo. dyor.
qp

[aqc888] 04/9/2021 19:57

I’m hoping some details will be released at the AGM on the 8th September, which would fit in well and gather attention for them, before attending the defence exhibition Kromek will exhibiting at on the 14th September at Excel in London.

hxxps://www.dsei.co.uk/



From DSEI summary of the event...

The focus on integration has been highlighted by the immense global impact of COVID-19 , and the enforced understanding that robust national resilience relies on more than fire power. With our adversaries increasingly posing non-military threats, greater instinctive integration is required at all levels of the defence community to ensure the UK remains ahead of the challenges that lie ahead.

[dexter1612] 04/9/2021 18:42

https://www.bbc.co.uk/news/health-58450524The case for the machines is compelling and growing by the day. Anyone any idea when the results of the trial will be released.

[quepassa] 03/9/2021 12:32

Same old same old

all imo. dyor.
qp

[nick2412] 01/9/2021 21:48

Thanks fr for the relevant email address. I'll send a couple of questions in and I'd encourage other holders to do likewise just as you would at a regular face to face agm.

[aqc888] 01/9/2021 18:16

I’d be very interested to hear how many biological pathogen detectors can be produced a year should the results prove positive.

[fanramptastic mate] 01/9/2021 18:00

1.6 Shareholders who would have raised questions at the AGM are invited to instead submit their questions by email to: [e-mail] in advance of the AGM.

We will endeavour to promptly provide answers to questions from shareholders that would ordinarily have been raised and answered at the AGM; such questions and answers will be published on the Company’s website following the Meeting.